245 related articles for article (PubMed ID: 17222504)
1. In search of tumor suppressing functions of menin.
Yang Y; Hua X
Mol Cell Endocrinol; 2007 Feb; 265-266():34-41. PubMed ID: 17222504
[TBL] [Abstract][Full Text] [Related]
2. Menin regulates endocrine diseases by controlling histone modification and gene transcription.
Gao SB; Hua X; Jin GH
Ann Endocrinol (Paris); 2008 Nov; 69(5):426-32. PubMed ID: 18752793
[TBL] [Abstract][Full Text] [Related]
3. Menin molecular interactions: insights into normal functions and tumorigenesis.
Agarwal SK; Kennedy PA; Scacheri PC; Novotny EA; Hickman AB; Cerrato A; Rice TS; Moore JB; Rao S; Ji Y; Mateo C; Libutti SK; Oliver B; Chandrasekharappa SC; Burns AL; Collins FS; Spiegel AM; Marx SJ
Horm Metab Res; 2005 Jun; 37(6):369-74. PubMed ID: 16001329
[TBL] [Abstract][Full Text] [Related]
4. A Review of the Scaffold Protein Menin and its Role in Hepatobiliary Pathology.
Ehrlich L; Hall C; Meng F; Lairmore T; Alpini G; Glaser S
Gene Expr; 2017 Jul; 17(3):251-263. PubMed ID: 28485270
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation.
Dreijerink KM; Höppener JW; Timmers HM; Lips CJ
Nat Clin Pract Endocrinol Metab; 2006 Oct; 2(10):562-70. PubMed ID: 17024155
[TBL] [Abstract][Full Text] [Related]
6. Tissue selectivity in multiple endocrine neoplasia type 1-associated tumorigenesis.
Gracanin A; Dreijerink KM; van der Luijt RB; Lips CJ; Höppener JW
Cancer Res; 2009 Aug; 69(16):6371-4. PubMed ID: 19654304
[TBL] [Abstract][Full Text] [Related]
7. MEN1 missense mutations impair sensitization to apoptosis induced by wild-type menin in endocrine pancreatic tumor cells.
Bazzi W; Renon M; Vercherat C; Hamze Z; Lacheretz-Bernigaud A; Wang H; Blanc M; Roche C; Calender A; Chayvialle JA; Scoazec JY; Cordier-Bussat M
Gastroenterology; 2008 Nov; 135(5):1698-1709.e2. PubMed ID: 18775714
[TBL] [Abstract][Full Text] [Related]
8. Multiple endocrine neoplasia type 1: a chromatin writer's block.
Dreijerink KM; Lips CJ; Timmers HT
J Intern Med; 2009 Jul; 266(1):53-9. PubMed ID: 19522825
[TBL] [Abstract][Full Text] [Related]
9. Multiple endocrine neoplasia type 1.
Agarwal SK
Front Horm Res; 2013; 41():1-15. PubMed ID: 23652667
[TBL] [Abstract][Full Text] [Related]
10. Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis.
Pieterman CR; Conemans EB; Dreijerink KM; de Laat JM; Timmers HT; Vriens MR; Valk GD
Endocr Relat Cancer; 2014 Jun; 21(3):R121-42. PubMed ID: 24389729
[TBL] [Abstract][Full Text] [Related]
11. Twenty years of menin: emerging opportunities for restoration of transcriptional regulation in MEN1.
Dreijerink KMA; Timmers HTM; Brown M
Endocr Relat Cancer; 2017 Oct; 24(10):T135-T145. PubMed ID: 28811299
[TBL] [Abstract][Full Text] [Related]
12. Accelerated proliferation and differential global gene expression in pancreatic islets of five-week-old heterozygous Men1 mice: Men1 is a haploinsufficient suppressor.
Lejonklou MH; Barbu A; Stålberg P; Skogseid B
Endocrinology; 2012 Jun; 153(6):2588-98. PubMed ID: 22492302
[TBL] [Abstract][Full Text] [Related]
13. Menin dynamics and functional insight: take your partners.
Balogh K; Patócs A; Hunyady L; Rácz K
Mol Cell Endocrinol; 2010 Sep; 326(1-2):80-4. PubMed ID: 20399832
[TBL] [Abstract][Full Text] [Related]
14. Menin critically links MLL proteins with LEDGF on cancer-associated target genes.
Yokoyama A; Cleary ML
Cancer Cell; 2008 Jul; 14(1):36-46. PubMed ID: 18598942
[TBL] [Abstract][Full Text] [Related]
15. Menin-mediated caspase 8 expression in suppressing multiple endocrine neoplasia type 1.
La P; Yang Y; Karnik SK; Silva AC; Schnepp RW; Kim SK; Hua X
J Biol Chem; 2007 Oct; 282(43):31332-40. PubMed ID: 17766243
[TBL] [Abstract][Full Text] [Related]
16. Molecular and genetic mechanisms of tumorigenesis in multiple endocrine neoplasia type-1.
Guo SS; Sawicki MP
Mol Endocrinol; 2001 Oct; 15(10):1653-64. PubMed ID: 11579199
[TBL] [Abstract][Full Text] [Related]
17. MEN1 tumor-suppressor protein localizes to telomeres during meiosis.
Suphapeetiporn K; Greally JM; Walpita D; Ashley T; Bale AE
Genes Chromosomes Cancer; 2002 Sep; 35(1):81-5. PubMed ID: 12203793
[TBL] [Abstract][Full Text] [Related]
18. Reconstituted expression of menin in Men1-deficient mouse Leydig tumour cells induces cell cycle arrest and apoptosis.
Hussein N; Casse H; Fontanière S; Morera AM; Asensio MJ; Bakeli S; Lu JL; Coste I; Di Clemente N; Bertolino P; Zhang CX
Eur J Cancer; 2007 Jan; 43(2):402-14. PubMed ID: 17184987
[TBL] [Abstract][Full Text] [Related]
19. Ribozyme-mediated compensatory induction of menin-oncosuppressor function in primary fibroblasts from MEN1 patients.
Luzi E; Marini F; Tognarini I; Carbonell Sala S; Galli G; Falchetti A; Brandi ML
Cancer Gene Ther; 2010 Nov; 17(11):814-25. PubMed ID: 20706287
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide analysis of menin binding provides insights into MEN1 tumorigenesis.
Scacheri PC; Davis S; Odom DT; Crawford GE; Perkins S; Halawi MJ; Agarwal SK; Marx SJ; Spiegel AM; Meltzer PS; Collins FS
PLoS Genet; 2006 Apr; 2(4):e51. PubMed ID: 16604156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
